Literature DB >> 16697536

The cyclin-like uracil DNA glycosylase (UDG) of murine oocytes and its relationship to human and chimpanzee homologues.

Rachel Hirst1, Roger Gosden, David Miller.   

Abstract

Examination of electrophoretically resolved randomly generated PCR amplicons from mature murine oocytes revealed the presence of a short sequence with partial homology to a cyclin-like human uracil DNA glycosylase (UDG2), a member of an important group of base-excision enzymes that remove misincorporated or cytosine-derived uracil from nascent DNA. A combination of 3' R.A.C.E. and in silico 'cloning' of the 5' region of the original EST uncovered a predicted murine mRNA sequence with limited homology to human UDG2 at both nucleotide and amino acid levels. An alternative contig for human UDG2 showed stronger similarity with the homologous murine and chimp genomic and protein sequences and contained both N and C terminal cyclin box elements. This contig is also an Ensembl annotated alternative splice-site variant of the UDG2 gene (Udg2v2). We suggest that uracil-excision repair in oocytes is likely to be mediated by Udg2v2, or alternatively that Udg2v2 is involved in a process related to oocyte-specific maturation by virtue of its cyclin-like domains.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16697536     DOI: 10.1016/j.gene.2006.02.030

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  Phosphorylation of cyclin O, a novel cyclin family protein containing a cyclin-like domain, is involved in the activation of cyclin-dependent kinase 2.

Authors:  DO Hyung Kim; Jong-Hwa Park; Bora Lee; Kyoung Ok Jang; In Sik Chung; Ye Sun Han
Journal:  Oncol Lett       Date:  2014-09-12       Impact factor: 2.967

2.  Hyaluronic Acid Binding Sperm Selection for assisted reproduction treatment (HABSelect): study protocol for a multicentre randomised controlled trial.

Authors:  K D Witt; L Beresford; S Bhattacharya; K Brian; A Coomarasamy; Rachel Cutting; R Hooper; J Kirkman-Brown; Y Khalaf; S E Lewis; A Pacey; S Pavitt; R West; D Miller
Journal:  BMJ Open       Date:  2016-10-07       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.